{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:35:08Z","timestamp":1785407708402,"version":"3.56.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Inverted urothelial papilloma (IUP) is a benign neoplasm characterized by a downgrowth of the urothelium beneath the surface of morphologically normal urothelial cells; however, the molecular features of IUP and their association with clinicopathological characteristics are unclear. In this study, we aimed to investigate the mutational landscape, clinicopathological features, genotype-phenotype associations, and spread patterns of IUP. We performed targeted next-generation sequencing of 39 consecutive IUP cases, the largest series investigated to date, and identified oncogenic driver mutations in RAS family genes in 34 cases (87%). <jats:italic toggle=\"yes\">HRAS<\/jats:italic> mutations were the most prevalent (28 cases), which included Q61R (15 cases), followed by <jats:italic toggle=\"yes\">KRAS<\/jats:italic> (5 cases) and <jats:italic toggle=\"yes\">NRAS<\/jats:italic> (1 case) mutations. Characteristic mutations observed in urothelial carcinoma, including those in <jats:italic toggle=\"yes\">FGFR3<\/jats:italic>, <jats:italic toggle=\"yes\">TP53<\/jats:italic>, or the <jats:italic toggle=\"yes\">TERT<\/jats:italic> promoter, were absent. <jats:italic toggle=\"yes\">HRAS<\/jats:italic>-mutated IUPs were associated with a history of smoking (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.017) and streaming morphology (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), corresponding to the trabecular subtype. In contrast, all <jats:italic toggle=\"yes\">KRAS<\/jats:italic>-mutated IUPs occurred in never-smoking patients (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001) and showed cystic changes in morphology (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005), corresponding to the glandular subtype. RAS Q61R immunohistochemistry visually revealed the neoplastic nature of the overlying cells and distinct spread patterns of IUP cells within the surface, including pseudoinfiltrative spread. No recurrence or carcinoma development was observed in any of the IUP cases during the follow-up period. Thus, we confirmed the importance of RAS pathway activation in IUP pathogenesis, an association between RAS family gene mutations and IUP subtypes, and the spread patterns of IUP cells within the surface.<\/jats:p>","DOI":"10.1097\/pas.0000000000002171","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T15:01:08Z","timestamp":1703516468000},"page":"458-464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of Inverted Urothelial Papilloma of the Bladder"],"prefix":"10.1097","volume":"48","author":[{"given":"Keiichiro","family":"Kitahama","sequence":"first","affiliation":[{"name":"Division of Pathology, The Cancer Institute"},{"name":"Department of Pathology, The Cancer Institute Hospital"},{"name":"Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Shigematsu","sequence":"additional","affiliation":[{"name":"Division of Pathology, The Cancer Institute"},{"name":"Department of Pathology, The Cancer Institute Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulanbar","family":"Amori","sequence":"additional","affiliation":[{"name":"Division of Pathology, The Cancer Institute"},{"name":"Department of Pathology, The Cancer Institute Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Division of Pathology, The Cancer Institute"},{"name":"Department of Pathology, The Cancer Institute Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yonese","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, The Cancer Institute Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Shibahara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Pathology, The Cancer Institute"},{"name":"Department of Pathology, The Cancer Institute Hospital"},{"name":"Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Inamura","sequence":"additional","affiliation":[{"name":"Division of Pathology, The Cancer Institute"},{"name":"Department of Pathology, The Cancer Institute Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/cncr.22311","article-title":"Natural history of urothelial inverted papilloma","volume":"107","author":"Sung","year":"2006","journal-title":"Cancer"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/1097-0142(19830115)51:2<348::AID-CNCR2820510231>3.0.CO;2-O","article-title":"Histology and histogenesis of two different types of inverted urothelial papillomas","volume":"51","author":"Kunze","year":"1983","journal-title":"Cancer"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0022-5347(01)64253-8","article-title":"The prognostic value of a primary inverted papilloma of the urinary tract","volume":"158","author":"Witjes","year":"1997","journal-title":"J Urol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.urolonc.2012.03.009","article-title":"Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients","volume":"31","author":"Picozzi","year":"2013","journal-title":"Urol Oncol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.pas.0000249448.13466.75","article-title":"Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract","volume":"31","author":"Eiber","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-5347(17)64384-2","article-title":"Inverted papilloma of the bladder","volume":"90","author":"Potts","year":"1963","journal-title":"J Urol"},{"key":"R7-20250608","first-page":"136","article-title":"Inverted Urothelial Papilloma","author":"Raspollini","year":"2022","journal-title":"Urinary and male genital tumours"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"151433","DOI":"10.1016\/j.anndiagpath.2019.151433","article-title":"Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: reclassification by international consultation on urologic disease (ICUD) recommendations","volume":"44","author":"Bang","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.urology.2013.06.040","article-title":"Long-term clinical outcome of inverted urothelial papilloma including cases with focal papillary pattern: is continuous surveillance necessary?","volume":"82","author":"Patel","year":"2013","journal-title":"Urology"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00000478-199709000-00010","article-title":"Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases","volume":"21","author":"Amin","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"e0133530","DOI":"10.1371\/journal.pone.0133530","article-title":"Immunohistochemistry and fluorescence in situ hybridization can inform the differential diagnosis of low-grade noninvasive urothelial carcinoma with an inverted growth pattern and inverted urothelial papilloma","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2010.09853.x","article-title":"Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management","volume":"107","author":"Hodges","year":"2011","journal-title":"BJU Int"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/clinpract11010017","article-title":"Mimickers of urothelial carcinoma and the approach to differential diagnosis","volume":"11","author":"Manini","year":"2021","journal-title":"Clin Pract"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.humpath.2014.06.003","article-title":"HRAS mutations are frequent in inverted urothelial neoplasms","volume":"45","author":"McDaniel","year":"2014","journal-title":"Hum Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/path.5261","article-title":"Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder","volume":"248","author":"Isharwal","year":"2019","journal-title":"J Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/modpathol.2009.28","article-title":"FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations","volume":"22","author":"Lott","year":"2009","journal-title":"Mod Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.5307","article-title":"Distinct mutational landscape of inverted urothelial papilloma","volume":"249","author":"Akgul","year":"2019","journal-title":"J Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/path.5390","article-title":"Inverted urothelial papilloma and urothelial carcinoma with inverted growth are histologically and molecularly distinct entities","volume":"250","author":"Almassi","year":"2020","journal-title":"J Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/his.13441","article-title":"Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential","volume":"72","author":"Wang","year":"2018","journal-title":"Histopathology"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/his.12920","article-title":"Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant, and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change","volume":"69","author":"Cheng","year":"2016","journal-title":"Histopathology"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/modpathol.3800667","article-title":"Inverted papilloma of the urinary bladder: a molecular genetic appraisal","volume":"19","author":"Sung","year":"2006","journal-title":"Mod Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/his.12030","article-title":"Telomere shortening distinguishes inverted urothelial neoplasms","volume":"62","author":"Williamson","year":"2013","journal-title":"Histopathology"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"841398","DOI":"10.3389\/fonc.2022.841398","article-title":"Proteomic-based machine learning analysis reveals PYGB as a novel immunohistochemical biomarker to distinguish inverted urothelial papilloma from low-grade papillary urothelial carcinoma with inverted growth","volume":"12","author":"Jung","year":"2022","journal-title":"Front Oncol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.humpath.2006.05.014","article-title":"Inverted urothelial papillomas with foamy or vacuolated cytoplasm","volume":"37","author":"Fine","year":"2006","journal-title":"Hum Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/PAS.0000000000001673","article-title":"The diagnostic utility of RAS Q61R mutation-specific immunohistochemistry in epithelial-myoepithelial carcinoma","volume":"45","author":"Nakaguro","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur Urol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cancers10040100","article-title":"Bladder cancer: new insights into its molecular pathology","volume":"10","author":"Inamura","year":"2018","journal-title":"Cancers (Basel)"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/path.2047","article-title":"Senescence and serration: a new twist to an old tale","volume":"210","author":"Minoo","year":"2006","journal-title":"J Pathol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumours: evidence from mice and humans","volume":"10","author":"Collado","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer\u2014role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"R35-20250608","first-page":"145","article-title":"Development of urinary bladder cancer in the rat","volume":"67","author":"Kunze","year":"1979","journal-title":"Curr Top Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:00:30Z","timestamp":1749412830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002171","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}